Avaliação do efeito do citral na dor neuropática e na inflamação

Detalhes bibliográficos
Autor(a) principal: Nishijima, Catarine Massucato [UNESP]
Data de Publicação: 2014
Tipo de documento: Tese
Idioma: por
Título da fonte: Repositório Institucional da UNESP
Texto Completo: http://hdl.handle.net/11449/123841
http://www.athena.biblioteca.unesp.br/exlibris/bd/cathedra/11-05-2015/000823617.pdf
Resumo: Injuries to the system peripheral nervous that result in neuropathic pain may evolve substantial functional loss and decreased quality of life of patients by permanent loss of sensory-motor functions. Surgeries such as breast, cardiac, thoracic, abdominal surgeries, caesarean and amputations culminate with the acute postoperative pain (APP) followed by persistent pain. Approximately 10% of patients develop chronic pain lasting between 3-6 months after surgery. The sensation of pain is exacerbated by simple activities such as walking, coughing and innocuous stimuli as touch and temperature. Another clinical condition investigated in this work is the chronic pain in Complex Regional Pain Syndrome type I (CRPS- I). CRPS- I is a multifactorial chronic neuropathy, resulting from deep tissue injury such as sprains, fractures, tourniquet, heart attack, stroke and vascular changes as Raynaud's phenomenon. The clinical management of neuropathic pain is complex, since it shows refractory to medications available, so this is the reason to evaluation of new agents with potential antinociceptive. Citral, a terpene widely found in essential oils of lemongrass, melissa, among other species, have been studied for its pharmacological properties, such as its agonist effect on channels TRP (transient receptor potential). In this work, we found that citral, at the doses of 100 mg/kg and 300 mg/kg (p.o), has antinociceptive and antiinflammatory in models of acute nociception and inflammation (formalin test, hot plate, acute postoperative pain and edema xylene -induced ear) without modifying the coordination and locomotor performance of the animals. Mice have exhibited a reduction of nociceptive threshold in chronic pain models after ischemia and reperfusion and partial sciatic nerve constriction with a maximal effect obtained at the dose of 100 mg/kg (p.o.) between 1 and 2 hours after administration. Citral (100 mg/kg, p.o.) was able to inhibit the licking ...
id UNSP_e0af8218ba78c7eccce16851d80d3e7b
oai_identifier_str oai:repositorio.unesp.br:11449/123841
network_acronym_str UNSP
network_name_str Repositório Institucional da UNESP
repository_id_str 2946
spelling Avaliação do efeito do citral na dor neuropática e na inflamaçãoSistema nervoso - Ferimentos e lesõesNeuropatiaDor pós-operatóriaTerpenosPostoperative painInjuries to the system peripheral nervous that result in neuropathic pain may evolve substantial functional loss and decreased quality of life of patients by permanent loss of sensory-motor functions. Surgeries such as breast, cardiac, thoracic, abdominal surgeries, caesarean and amputations culminate with the acute postoperative pain (APP) followed by persistent pain. Approximately 10% of patients develop chronic pain lasting between 3-6 months after surgery. The sensation of pain is exacerbated by simple activities such as walking, coughing and innocuous stimuli as touch and temperature. Another clinical condition investigated in this work is the chronic pain in Complex Regional Pain Syndrome type I (CRPS- I). CRPS- I is a multifactorial chronic neuropathy, resulting from deep tissue injury such as sprains, fractures, tourniquet, heart attack, stroke and vascular changes as Raynaud's phenomenon. The clinical management of neuropathic pain is complex, since it shows refractory to medications available, so this is the reason to evaluation of new agents with potential antinociceptive. Citral, a terpene widely found in essential oils of lemongrass, melissa, among other species, have been studied for its pharmacological properties, such as its agonist effect on channels TRP (transient receptor potential). In this work, we found that citral, at the doses of 100 mg/kg and 300 mg/kg (p.o), has antinociceptive and antiinflammatory in models of acute nociception and inflammation (formalin test, hot plate, acute postoperative pain and edema xylene -induced ear) without modifying the coordination and locomotor performance of the animals. Mice have exhibited a reduction of nociceptive threshold in chronic pain models after ischemia and reperfusion and partial sciatic nerve constriction with a maximal effect obtained at the dose of 100 mg/kg (p.o.) between 1 and 2 hours after administration. Citral (100 mg/kg, p.o.) was able to inhibit the licking ...Lesões do sistema nervoso periférico que resultam em dor neuropática podem evoluir em substancial perda funcional e diminuição da qualidade de vida do paciente pelo permanente prejuízo das funções sensório-motoras. Cirurgias comuns tais como cirurgia da mama, cirurgias cardíacas, torácicas, abdominais, cesarianas e amputações culminam com o quadro de dor aguda pós-operatória (DPO) seguida de dor persistente. Aproximadamente 10 % dos pacientes evoluem para dor crônica com duração entre 3 a 6 meses após a cirurgia. A sensação dolorosa é exacerbada por atividades cotidianas como caminhar, tossir e por estímulos inócuos como toque e temperatura. Outra condição clínica investigada no presente trabalho é a dor crônica na Síndrome da Dor Complexa Regional do tipo I (SDCR-I). SDCR-I é uma neuropatia crônica de origem multifatorial, decorrente de injúria tecidual profunda tais como torções, fraturas, utilização de torniquete, infarto, acidente vascular encefálico e alterações vasculares como no fenômeno de Raynaud. A condução clínica da dor neuropática é complexa, uma vez que ela se mostra refratária a maioria dos medicamentos analgésicos disponíveis no mercado, razão pela qual existe um grande interesse na avaliação de novos agentes com potencial anti-nociceptivo. Citral, um terpeno amplamente encontrado em óleos essenciais de capim-cidreira, melissa, citronela, entre outras espécies vegetais, tem se destacado pelas suas propriedades farmacológicas, dentre elas seu efeito agonista em canais TRPs (receptor de potencial transitório). Neste trabalho constatamos que citral nas doses de 100 mg/kg e 300 mg/kg (p.o) apresenta atividade antinociceptiva e anti-inflamatória em modelos agudos de nocicepção e inflamação (teste da formalina, placa quente, dor aguda pós-operatória e edema de orelha induzido por xilol) sem alterar a coordenação e a performance locomotora dos animais. Animais ...Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Universidade Estadual Paulista (Unesp)Hiruma-Lima, Clélia Akiko [UNESP]Universidade Estadual Paulista (Unesp)Nishijima, Catarine Massucato [UNESP]2015-06-17T19:34:05Z2015-06-17T19:34:05Z2014-02-19info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/doctoralThesis119 f.application/pdfNISHIJIMA, Catarine Massucato. Avaliação do efeito do citral na dor neuropática e na inflamação. 2014. 119 f. Tese (doutorado) - Universidade Estadual Paulista Júlio de Mesquita Filho, Instituto de Biociências de Botucatu, 2014.http://hdl.handle.net/11449/123841000823617http://www.athena.biblioteca.unesp.br/exlibris/bd/cathedra/11-05-2015/000823617.pdf33004064052P038145049013868440000-0002-8645-3777Alephreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPporinfo:eu-repo/semantics/openAccess2023-11-29T06:15:40Zoai:repositorio.unesp.br:11449/123841Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462023-11-29T06:15:40Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false
dc.title.none.fl_str_mv Avaliação do efeito do citral na dor neuropática e na inflamação
title Avaliação do efeito do citral na dor neuropática e na inflamação
spellingShingle Avaliação do efeito do citral na dor neuropática e na inflamação
Nishijima, Catarine Massucato [UNESP]
Sistema nervoso - Ferimentos e lesões
Neuropatia
Dor pós-operatória
Terpenos
Postoperative pain
title_short Avaliação do efeito do citral na dor neuropática e na inflamação
title_full Avaliação do efeito do citral na dor neuropática e na inflamação
title_fullStr Avaliação do efeito do citral na dor neuropática e na inflamação
title_full_unstemmed Avaliação do efeito do citral na dor neuropática e na inflamação
title_sort Avaliação do efeito do citral na dor neuropática e na inflamação
author Nishijima, Catarine Massucato [UNESP]
author_facet Nishijima, Catarine Massucato [UNESP]
author_role author
dc.contributor.none.fl_str_mv Hiruma-Lima, Clélia Akiko [UNESP]
Universidade Estadual Paulista (Unesp)
dc.contributor.author.fl_str_mv Nishijima, Catarine Massucato [UNESP]
dc.subject.por.fl_str_mv Sistema nervoso - Ferimentos e lesões
Neuropatia
Dor pós-operatória
Terpenos
Postoperative pain
topic Sistema nervoso - Ferimentos e lesões
Neuropatia
Dor pós-operatória
Terpenos
Postoperative pain
description Injuries to the system peripheral nervous that result in neuropathic pain may evolve substantial functional loss and decreased quality of life of patients by permanent loss of sensory-motor functions. Surgeries such as breast, cardiac, thoracic, abdominal surgeries, caesarean and amputations culminate with the acute postoperative pain (APP) followed by persistent pain. Approximately 10% of patients develop chronic pain lasting between 3-6 months after surgery. The sensation of pain is exacerbated by simple activities such as walking, coughing and innocuous stimuli as touch and temperature. Another clinical condition investigated in this work is the chronic pain in Complex Regional Pain Syndrome type I (CRPS- I). CRPS- I is a multifactorial chronic neuropathy, resulting from deep tissue injury such as sprains, fractures, tourniquet, heart attack, stroke and vascular changes as Raynaud's phenomenon. The clinical management of neuropathic pain is complex, since it shows refractory to medications available, so this is the reason to evaluation of new agents with potential antinociceptive. Citral, a terpene widely found in essential oils of lemongrass, melissa, among other species, have been studied for its pharmacological properties, such as its agonist effect on channels TRP (transient receptor potential). In this work, we found that citral, at the doses of 100 mg/kg and 300 mg/kg (p.o), has antinociceptive and antiinflammatory in models of acute nociception and inflammation (formalin test, hot plate, acute postoperative pain and edema xylene -induced ear) without modifying the coordination and locomotor performance of the animals. Mice have exhibited a reduction of nociceptive threshold in chronic pain models after ischemia and reperfusion and partial sciatic nerve constriction with a maximal effect obtained at the dose of 100 mg/kg (p.o.) between 1 and 2 hours after administration. Citral (100 mg/kg, p.o.) was able to inhibit the licking ...
publishDate 2014
dc.date.none.fl_str_mv 2014-02-19
2015-06-17T19:34:05Z
2015-06-17T19:34:05Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/doctoralThesis
format doctoralThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv NISHIJIMA, Catarine Massucato. Avaliação do efeito do citral na dor neuropática e na inflamação. 2014. 119 f. Tese (doutorado) - Universidade Estadual Paulista Júlio de Mesquita Filho, Instituto de Biociências de Botucatu, 2014.
http://hdl.handle.net/11449/123841
000823617
http://www.athena.biblioteca.unesp.br/exlibris/bd/cathedra/11-05-2015/000823617.pdf
33004064052P0
3814504901386844
0000-0002-8645-3777
identifier_str_mv NISHIJIMA, Catarine Massucato. Avaliação do efeito do citral na dor neuropática e na inflamação. 2014. 119 f. Tese (doutorado) - Universidade Estadual Paulista Júlio de Mesquita Filho, Instituto de Biociências de Botucatu, 2014.
000823617
33004064052P0
3814504901386844
0000-0002-8645-3777
url http://hdl.handle.net/11449/123841
http://www.athena.biblioteca.unesp.br/exlibris/bd/cathedra/11-05-2015/000823617.pdf
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 119 f.
application/pdf
dc.publisher.none.fl_str_mv Universidade Estadual Paulista (Unesp)
publisher.none.fl_str_mv Universidade Estadual Paulista (Unesp)
dc.source.none.fl_str_mv Aleph
reponame:Repositório Institucional da UNESP
instname:Universidade Estadual Paulista (UNESP)
instacron:UNESP
instname_str Universidade Estadual Paulista (UNESP)
instacron_str UNESP
institution UNESP
reponame_str Repositório Institucional da UNESP
collection Repositório Institucional da UNESP
repository.name.fl_str_mv Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)
repository.mail.fl_str_mv
_version_ 1797789853461512192